SCHEMBL16094288

SCHEMBL16094288

CCCNc1nc(NC)c2nc(N(CCO)CCO)nc(NC)c2n1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC29A1 Q99808 18/20 0.72
PRUNE1 Q86TP1 2/20 0.43
CCNE2 O96020 1/20 0.34
CCNE1 P24864 1/20 0.34
CDK2 P24941 1/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
PDE2A O00408 1/20 0.34
RGS12 O14924 1/20 0.34
SLC22A2 O15244 1/20 0.34
SLC22A1 O15245 1/20 0.34
ABCC4 O15439 1/20 0.34
ABCC5 O15440 1/20 0.34
PDE6D O43924 1/20 0.34
PDE8A O60658 1/20 0.34
GMNN O75496 1/20 0.34
USP2 O75604 1/20 0.34
PDE5A O76074 1/20 0.34
ABCB11 O95342 1/20 0.34
ALDH1A1 P00352 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL17494537 0.99 SLC29A1 (0.70) SLC29A1PRUNE1CCNE2CCNE1CDK2
SCHEMBL16094717 0.88 SLC29A1 (0.55) SLC29A1PRUNE1
SCHEMBL16094237 0.84 SLC29A1 (0.50) SLC29A1PRUNE1CCNE2CCNE1CDK2
SCHEMBL20179388 0.82 SLC29A1 (0.66) SLC29A1CCNE2CCNE1CDK2KDM4E
SCHEMBL16094477 0.81 SLC29A1 (0.44) SLC29A1MEN1ALDH1A1LMNACYP2C19
SCHEMBL16094563 0.81 SLC29A1 (0.46) SLC29A1MEN1LMNACYP2C19KMT2A
Hydrochloric Acid SCHEMBL20164590 0.81 SLC29A1 (0.64) SLC29A1CCNE2CCNE1CDK2KDM4E
SCHEMBL13295563 0.81 SLC29A1 (0.66) SLC29A1PRUNE1MEN1LMNAGAA
SCHEMBL16094704 0.81 SLC29A1 (0.51) SLC29A1MEN1LMNACYP2C19KMT2A
Hydrochloric Acid SCHEMBL16094696 0.79 SLC29A1 (0.50) SLC29A1MEN1LMNAGAACYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9643971-B2 Breathing control modulating compounds, and methods of using same GALLEON PHARMACEUTICALS, INC. (US) 2017-05-09 US claimed
US-20160046635-A1 NOVEL BREATHING CONTROL MODULATING COMPOUNDS, AND METHODS OF USING SAME GALLEON PHARMACEUTICALS, INC. 2016-02-18 US claimed
US-9643971-B2 Breathing control modulating compounds, and methods of using same GALLEON PHARMACEUTICALS, INC. (US) 2017-05-09 US disclosed
US-20160046635-A1 NOVEL BREATHING CONTROL MODULATING COMPOUNDS, AND METHODS OF USING SAME GALLEON PHARMACEUTICALS, INC. 2016-02-18 US disclosed
EP-2968329-A1 NOVEL BREATHING CONTROL MODULATING COMPOUNDS, AND METHODS OF USING SAME Galleon Pharmaceuticals, Inc. (US) 2016-01-20 EP disclosed
WO-2014151462-A1 NOVEL BREATHING CONTROL MODULATING COMPOUNDS, AND METHODS OF USING SAME GALLEON PHARMACEUTICALS, INC. (US) 2014-09-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160046635-A1 NOVEL BREATHING CONTROL MODULATING COMPOUNDS, AND METHODS OF USING SAME PRDX5, QDPR, P2RX5 SLC29A1 1696/4885PRUNE1 689/4885CCNE2 2612/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.